Literature DB >> 10574881

Screening of newborn infants for cholestatic hepatobiliary disease. Does test fulfil screening criteria?

E Linnane, A Paul, R Parry.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10574881      PMCID： PMC1117162          DOI： 10.1136/bmj.319.7222.1435b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Screening of newborn infants for cholestatic hepatobiliary disease with tandem mass spectrometry.

Authors:  I Mushtaq; S Logan; M Morris; A W Johnson; A M Wade; D Kelly; P T Clayton
Journal:  BMJ       Date:  1999-08-21

Review 2.  Earlier identification of biliary atresia and hepatobiliary disease: selective screening in the third week of life.

Authors:  A P Mowat; L L Davidson; M C Dick
Journal:  Arch Dis Child       Date:  1995-01       Impact factor: 3.791

Review 3.  Oral versus intramuscular phytomenadione: safety and efficacy compared.

Authors:  R von Kries
Journal:  Drug Saf       Date:  1999-07       Impact factor: 5.606

4.  Long-term postsurgical outcome of biliary atresia.

Authors:  T Okazaki; H Kobayashi; A Yamataka; G J Lane; T Miyano
Journal:  J Pediatr Surg       Date:  1999-02       Impact factor: 2.545
  4 in total
  2 in total

1.  Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years.

Authors:  Anne Andermann; Ingeborg Blancquaert; Sylvie Beauchamp; Véronique Déry
Journal:  Bull World Health Organ       Date:  2008-04       Impact factor: 9.408

2.  Clinical examination and patients' history are not suitable for neonatal hip screening.

Authors:  Christian Maximilian Ziegler; Katharina Maria Ertl; Maria Delius; Kai Martin Foerster; Alexander Crispin; Ferdinand Wagner; Bernhard Heimkes
Journal:  J Child Orthop       Date:  2022-04-05       Impact factor: 1.917
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.